Watchlist Price Alert

Enlivex Therapeutics Ltd. (ENLV)

NASDAQ: ENLV · Real-Time Price · USD

1.10

0.05 (4.76%)

At close: May 06, 2025, 3:54 PM

1.12

1.58%

After-hours: May 06, 2025, 05:04 PM EDT

Enlivex Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-15.01M	-29.07M	-31.06M	-14.47M	-11.82M	-9.38M	-4.24M	-5.95M	-16.02M
Depreciation & Amortization	545K	835K	777K	546K	286K	206K	121K	64K	38K
Stock-Based Compensation	n/a	1.95M	2.71M	2.91M	670K	810K	1.01M	408K	700K
Other Working Capital	-1.64M	-1.3M	-364K	-1.8M	-342K	926K	-62K	18K	471K
Other Non-Cash Items	2.68M	4.58M	2.81M	413K	167K	168K	-132K	7K	39K
Deferred Income Tax	n/a	n/a	n/a	-5.59M	n/a	119K	n/a	n/a	n/a
Change in Working Capital	-1.22M	-1.82M	804K	-1.36M	-306K	1.04M	83K	-886K	-241K
Operating Cash Flow	-13.01M	-23.52M	-23.95M	-17.54M	-11.01M	-7.04M	-3.16M	-6.35M	-15.49M
Capital Expenditures	-103K	-236K	-8.12M	-1.63M	-1.02M	-193K	-461K	-2K	-18K
Cash Acquisitions	n/a	n/a	-9.71M	-20.03M	n/a	1.55M	n/a	9K	n/a
Purchase of Investments	-32.37M	-26.17M	-1.61M	-104.42M	-19.96M	-7.71M	-40K	n/a	n/a
Sales Maturities Of Investments	39.24M	301K	72.25M	67.63M	n/a	-1.55M	n/a	3M	9M
Other Investing Acitivies	2.29M	133K	9.71M	20.03M	-19.96K	1.55M	-32K	3.01M	9M
Investing Cash Flow	9.06M	-25.97M	62.52M	-38.41M	-20.98M	-6.36M	-533K	3.01M	8.98M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2K	n/a	150K	7.81M	8.62M	599K	n/a	n/a	n/a
Financial Cash Flow	6.45M	360K	150K	60.98M	33.08M	8.31M	5.19M	8.05K	6.09M
Net Cash Flow	n/a	-49.13M	38.72M	4.62M	1.49M	-4.27M	731K	-3.35M	-415K
Free Cash Flow	-13.11M	-23.76M	-32.08M	-19.17M	-12.03M	-7.23M	-3.62M	-6.35M	-15.5M